Medof ME - Search Results

1

Deletion of either CD55 or CD97 ameliorates arthritis in mouse models.

Hoek RM, de Launay D, Kop EN, Yilmaz-Elis AS, Lin F, Reedquist KA, Verbeek JS, Medof ME, Tak PP, Hamann J. Hoek RM, et al. Among authors: medof me. Arthritis Rheum. 2010 Apr;62(4):1036-42. doi: 10.1002/art.27347. Arthritis Rheum. 2010. PMID: 20131275 Free article.

2

Bulk production and functional analyses of mouse CD55's native and deglycosylated active domains.

Lin F, Immormino RM, Shoham M, Medof ME. Lin F, et al. Among authors: medof me. Arch Biochem Biophys. 2001 Sep 1;393(1):67-72. doi: 10.1006/abbi.2001.2488. Arch Biochem Biophys. 2001. PMID: 11516162

3

Decay-accelerating factor confers protection against complement-mediated podocyte injury in acute nephrotoxic nephritis.

Lin F, Emancipator SN, Salant DJ, Medof ME. Lin F, et al. Among authors: medof me. Lab Invest. 2002 May;82(5):563-9. doi: 10.1038/labinvest.3780451. Lab Invest. 2002. PMID: 12003997 Free article.

4

Resonance assignments of the central complement control protein module pair of human decay accelerating factor.

Uhrínová S, Lin F, Uhrín D, Medof ME, Barlow PN. Uhrínová S, et al. Among authors: medof me. J Biomol NMR. 2002 Jun;23(2):167-8. J Biomol NMR. 2002. PMID: 12153048 No abstract available.

5

Markedly enhanced susceptibility to experimental autoimmune myasthenia gravis in the absence of decay-accelerating factor protection.

Lin F, Kaminski HJ, Conti-Fine BM, Wang W, Richmonds C, Medof ME. Lin F, et al. Among authors: medof me. J Clin Invest. 2002 Nov;110(9):1269-74. doi: 10.1172/JCI16086. J Clin Invest. 2002. PMID: 12417565 Free PMC article.

6

Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in acute nephrotoxic serum nephritis.

Lin F, Salant DJ, Meyerson H, Emancipator S, Morgan BP, Medof ME. Lin F, et al. Among authors: medof me. J Immunol. 2004 Feb 15;172(4):2636-42. doi: 10.4049/jimmunol.172.4.2636. J Immunol. 2004. PMID: 14764738

7

Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease.

Lin F, Spencer D, Hatala DA, Levine AD, Medof ME. Lin F, et al. Among authors: medof me. J Immunol. 2004 Mar 15;172(6):3836-41. doi: 10.4049/jimmunol.172.6.3836. J Immunol. 2004. PMID: 15004190

8

Complement regulators in extraocular muscle and experimental autoimmune myasthenia gravis.

Kaminski HJ, Li Z, Richmonds C, Lin F, Medof ME. Kaminski HJ, et al. Among authors: medof me. Exp Neurol. 2004 Oct;189(2):333-42. doi: 10.1016/j.expneurol.2004.06.005. Exp Neurol. 2004. PMID: 15380483

9

Decay-accelerating factor modulates induction of T cell immunity.

Heeger PS, Lalli PN, Lin F, Valujskikh A, Liu J, Muqim N, Xu Y, Medof ME. Heeger PS, et al. Among authors: medof me. J Exp Med. 2005 May 16;201(10):1523-30. doi: 10.1084/jem.20041967. Epub 2005 May 9. J Exp Med. 2005. PMID: 15883171 Free PMC article.

10

The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation.

O'Brien DP, Israel DA, Krishna U, Romero-Gallo J, Nedrud J, Medof ME, Lin F, Redline R, Lublin DM, Nowicki BJ, Franco AT, Ogden S, Williams AD, Polk DB, Peek RM Jr. O'Brien DP, et al. Among authors: medof me. J Biol Chem. 2006 May 12;281(19):13317-13323. doi: 10.1074/jbc.M601805200. Epub 2006 Mar 16. J Biol Chem. 2006. PMID: 16543227 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page